Detalles de la búsqueda
1.
Clinicopathological Profiles Associated with Discordant RAS Mutational Status between Liquid and Tissue Biopsies in a Real-World Cohort of Metastatic Colorectal Cancer.
Cancers (Basel);
15(14)2023 Jul 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37509239
2.
Efficacy and safety of FOLFIRI/aflibercept (FA) in an elderly population with metastatic colorectal cancer (mCRC) after failure of an oxaliplatin-based regimen.
PLoS One;
17(6): e0269399, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35657983
3.
Efficacy, safety and prognostic factors in patients with refractory metastatic colorectal cancer treated with trifluridine/tipiracil plus bevacizumab in a real-world setting.
Sci Rep;
12(1): 14612, 2022 08 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-36028552
4.
Prediction of survival in patients with advanced, refractory colorectal cancer in treatment with trifluridine/tipiracil: real-world vs clinical trial data.
Sci Rep;
11(1): 14321, 2021 07 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34253805
5.
Do Clinical Trials Meet Current Care Needs? Views of Digestive Oncology Specialists in Galicia (Spain) Using the Delphi Method.
Healthcare (Basel);
9(6)2021 Jun 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34205026
6.
First-line panitumumab plus capecitabine for the treatment of older patients with wild-type RAS metastatic colorectal cancer. The phase II, PANEL study.
J Geriatr Oncol;
11(8): 1263-1267, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32580916
7.
Efficacy and safety of FOLFIRI/aflibercept in second-line treatment of metastatic colorectal cancer in a real-world population: Prognostic and predictive markers.
Cancer Med;
8(3): 882-889, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30690930
8.
Impact of surgery and chemotherapy on von Willebrand factor and vascular endothelial growth factor levels in colorectal cancer.
Clin Transl Oncol;
7(4): 150-5, 2005 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-15960922
9.
Phase II trial of erlotinib plus capecitabine as first-line treatment for metastatic pancreatic cancer (XELTA study).
Anticancer Res;
33(2): 717-23, 2013 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-23393373
Resultados
1 -
9
de 9
1
Próxima >
>>